Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Gyre Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 46 | 48 | +2 |
| Shares | 2.61M | 3.41M | +800.4K (+30.7%) |
| Value | $20.1M | $25.1M | +$4.92M (+24.4%) |
New holders (10)
Institutions that held Gyre Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State of Wisconsin Investment Board | 37,670 | $276.9K | 0.00% |
| Alliancebernstein L.P. | 19,930 | $146.5K | 0.00% |
| Nuveen, LLC | 17,594 | $129.3K | 0.00% |
| Verition Fund Management LLC | 13,345 | $98.1K | 0.00% |
| STRS Ohio | 13,300 | $97.8K | 0.00% |
| Deutsche Bank AG | 10,927 | $80.3K | 0.00% |
| Raymond James Financial Inc | 650 | $4.78K | 0.00% |
| Principal Securities, Inc. | 85 | $625 | 0.00% |
| Rise Advisors, LLC | 54 | $397 | 0.00% |
| Essential Partners LLC | 2 | $15 | 0.00% |
Sold out (8)
Institutions that held Gyre Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Goldman Sachs Group Inc | 16,147 | $124.7K |
| Advantage Alpha Capital Partners LP | 13,663 | $105.5K |
| Corebridge Financial, Inc. | 3,417 | $26.4K |
| Lazard Asset Management LLC | 833 | $6.00K |
| Group One Trading, L.P. | 485 | $3.74K |
| EverSource Wealth Advisors, LLC | 22 | $170 |
| US Bancorp | 17 | $131 |
| True Wealth Design, LLC | 6 | $47 |